Keyphrases
Tumor Response
100%
Systemic Exposure
100%
Tumor Xenograft
100%
Human Solid Tumors
100%
Exposure-response
100%
9-aminocamptothecin
100%
Xenograft
28%
Lactones
28%
Highly Sensitive
14%
Clinical Trials
14%
Further Development
14%
Plasma Concentration
14%
Tumor
14%
Antitumor Activity
14%
Antitumor
14%
Pediatric Tumors
14%
Antitumor Effect
14%
Minimum Effective Dose
14%
Concentrations-time Profiles
14%
Area under the Concentration-time Curve
14%
Complete Response
14%
Partial Response
14%
Topoisomerase Inhibitors
14%
3-cycle
14%
Xenograft Model
14%
Oral Therapy
14%
Tumor Regression
14%
Childhood Solid Tumors
14%
Advanced Tumor
14%
Pharmacology, Toxicology and Pharmaceutical Science
Solid Malignant Neoplasm
100%
9 Aminocamptothecin
100%
Neoplasm
100%
Lactone
28%
Clinical Trial
14%
Antitumor Activity
14%
DNA Topoisomerase Inhibitor
14%
Tumor Regression
14%
Minimal Effective Dose
14%